Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor and ligand-activated transcription factor that regulates genes involved in adipogenesis, lipid metabolism, glucose homeostasis, insulin sensitivity, and inflammation. It plays a central role in energy balance and metabolism and is a therapeutic target for type 2 diabetes.
Forms heterodimers with RXRs, binds to PPREs on DNA, recruits coactivators or corepressors to modulate gene transcription involved in energy balance and metabolism. Synthetic agonists like thiazolidinediones improve insulin sensitivity by activating PPARγ-mediated gene programs.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).